Company news
Organogenesis Holdings Inc. news in 2024
Organogenesis Holdings Inc.'s news releases, calls and decks from 2024, newest first.
Organogenesis Expands Manufacturing Capacity to Support Future Growth
November 21, 2024
Organogenesis Commends Final LCDs
November 14, 2024
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
November 11, 2024
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
November 11, 2024
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
November 10, 2024
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
October 15, 2024
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
September 30, 2024
Organogenesis Shares ReNu® Program Update
August 7, 2024
Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results
August 7, 2024
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
July 14, 2024
Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference
June 5, 2024
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
May 8, 2024
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
May 1, 2024
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
April 15, 2024
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
April 2, 2024
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
February 28, 2024
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 11, 2024
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
February 7, 2024
Calls in 2024
- Organogenesis Holdings (NASDAQ:ORGO) Q3 2024 Earnings Call
Nov 12, 2024
Transcript - Organogenesis Holdings (NASDAQ:ORGO) Q2 2024 Earnings Call
Aug 8, 2024
Transcript - Organogenesis Holdings (NASDAQ:ORGO) Q1 2024 Earnings Call
May 9, 2024
Transcript - Organogenesis Holdings (NASDAQ:ORGO) Q4 2023 Earnings Call
Feb 29, 2024
Transcript